Titelia

Holdings of RA CAPITAL MANAGEMENT, L.P.

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
78 in 3 countries
Top ten
64.8 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Ascendis Pharma A/S 10,281,4962.4B $
2Vaxcyte Inc 11,474,599666.8M $
3Rhythm Pharmaceuticals Inc 6,666,837579.8M $
4Tyra Biosciences Inc 12,198,625467.2M $
5Sionna Therapeutics Inc 9,905,045397.1M $
6Edgewise Therapeutics Inc 10,428,437328.5M $
7Nuvalent Inc 2,534,145259.6M $
8Dianthus Therapeutics Inc 2,611,733219.2M $
9Mineralys Therapeutics Inc 7,692,750208.4M $
10SpyGlass Pharma Inc 8,021,117207.8M $
11Septerna Inc 6,995,858168.1M $
12Disc Medicine Inc 2,450,221156.7M $
13Janux Therapeutics Inc 11,189,693155.5M $
14BioCryst Pharmaceuticals Inc 15,827,186150.7M $
15Bicara Therapeutics Inc 7,255,993144.3M $
16Praxis Precision Medicines Inc 373,787120.4M $
17ZAI LAB LTD 5,707,262107.4M $
18Taysha Gene Therapies Inc 23,555,648105.3M $
19Vor BioPharma Inc 5,404,99896.4M $
20Geron Corp 63,771,36695M $
21ARS Pharmaceuticals Inc 10,860,97787.2M $
22Sarepta Therapeutics Inc 3,902,59684.9M $
23Spyre Therapeutics Inc 1,621,62081.8M $
24Evommune Inc 3,494,63880.3M $
25Climb Bio Inc 11,300,93977.4M $
26Solid Biosciences Inc 9,339,97867.2M $
27Artiva Biotherapeutics Inc 9,853,30263.5M $
28DAMORA THERAPEUTICS INC 2,399,31062.1M $
29Xencor Inc 4,897,23759.1M $
30LB Pharmaceuticals Inc 2,208,60454.5M $
31JADE BIOSCIENCES INC 3,671,08351.6M $
32Acumen Pharmaceuticals Inc 20,992,66949.5M $
334D Molecular Therapeutics Inc 5,049,77947M $
34Fulcrum Therapeutics Inc 6,053,96046.4M $
35Capricor Therapeutics Inc 1,507,84445.8M $
36Century Therapeutics Inc 17,754,43040.1M $
37Olema Pharmaceuticals Inc 2,600,00038.8M $
38LENZ Therapeutics Inc 4,178,82338.2M $
39Monopar Therapeutics Inc 667,20736.6M $
40PepGen Inc 20,064,54535.5M $
41Design Therapeutics Inc 2,972,97331.6M $
42Mirum Pharmaceuticals Inc 318,55429.4M $
43BioAge Labs Inc 1,650,64828.9M $
44Lexeo Therapeutics Inc 5,000,00028.7M $
45Assembly Biosciences Inc 1,020,41028.3M $
46Rezolute Inc 9,180,00028M $
47Aktis Oncology Inc 1,503,08426.9M $
48ALX Oncology Holdings Inc 13,011,84926.1M $
49Aclaris Therapeutics Inc 6,804,07225.5M $
50Ovid therapeutics Inc 10,714,00023.8M $
51Nkarta Inc 10,805,12922.8M $
52Travere Therapeutics Inc 746,84122.2M $
53GRAIL Inc 428,26622.1M $
54C4 Therapeutics Inc 8,000,00021M $
55Relmada Therapeutics Inc 2,947,36920.5M $
56Benitec Biopharma Inc 1,850,00019.7M $
57Sutro Biopharma Inc 715,30717.8M $
58Contineum Therapeutics Inc 1,296,01216.9M $
59SAB Biotherapeutics Inc 4,401,50016.9M $
60Inspire Medical Systems Inc 325,66316.8M $
61Anteris Technologies Global Corp 3,000,00016.7M $
62OnKure Therapeutics Inc 3,998,33316.6M $
63Hinge Health Inc 364,61314.1M $
64GeneDx Holdings Corp 209,88713.5M $
65Waystar Holding Corp 529,40012.8M $
66Palisade Bio Inc 7,124,11612.5M $
67Acrivon Therapeutics Inc 8,340,50811.6M $
68Atrium Therapeutics Inc 864,10211.6M $
69Karyopharm Therapeutics Inc 1,917,35410.7M $
70AVALO THERAPEUTICS INC 662,9689.9M $
71Adicet Bio Inc 1,182,6248.1M $
72Corvus Pharmaceuticals Inc 450,0006.6M $
73Rani Therapeutics Holdings Inc 8,500,0006.2M $
74Equillium Inc 3,096,3366.2M $
75WEREWOLF THERAPEUTICS INC 6,681,3075.6M $
76MacroGenics Inc 1,864,1765.4M $
77MapLight Therapeutics Inc 248,2945M $
78PALATIN TECHNOLOGIES INC 70,0001.2M $

Download this table: CSV, JSON

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 72.0 %
  • Denmark 26.8 %
  • Cayman Islands 1.2 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States766.3B $72.00 %
2Denmark12.4B $26.78 %
3Cayman Islands1107.4M $1.22 %
Cite this page

Titelia. "Holdings of RA CAPITAL MANAGEMENT, L.P.". https://titelia.com/en/funds/US13F1346824